It is well known that noncoding RNAs (ncRNAs) cannot encode proteins, but they can play
important regulatory roles in tumors by combining with proteins, RNAs, and DNAs. As more …

Non-coding RNAs (ncRNAs) comprise a diversity of RNA species, which do not have the
potential to encode proteins. Non-coding RNAs include two classes of RNAs, namely: short …

The ability to detect cancer at an early stage in patients who would benefit from effective
therapy is a key factor in increasing survivability. This work proposes an evolutionary …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths worldwide.
Recently, microRNAs (miRNAs) are reported to be altered and act as potential biomarkers in …

Bladder urothelial carcinoma (BLC) is one of the most common cancers in men, and its
heterogeneity challenges the treatment to cure this disease. Recently, microRNAs (miRNAs) …

Background Extranodal extension (ENE) in head and neck squamous cell carcinoma
(HNSCC) correlates to poor prognoses and influences treatment strategies. Deep learning …

Abstract Background and Aims: Current prediction models for early recurrence of
hepatocellular carcinoma (HCC) after surgical resection remain unsatisfactory. The aim of …

Objective Hepatocellular carcinoma (HCC) is one of the leading cancer types with
increasing annual incidence and high mortality in the USA. MicroRNAs (miRNAs) have …

Background Thyroid carcinoma is a malignancy with high morbidity and mortality. Genetic
alterations play pivot roles in the pathogenesis of thyroid carcinoma, where long noncoding …

Ovarian cancer is a major gynaecological malignant tumor associated with a high mortality
rate. Identifying survival-related variants may improve treatment and survival in patients with …